The cost of newly-launched pharmaceuticals in the United States soared in 2024. Median annual list prices of US drug prices more than doubled compared to 2021. A Reuters analysis highlights that this sharp increase is attributed mainly to companies leveraging significant scientific advancements. This has developed more treatments for rare diseases, which traditionally command high prices. The median annual list…